How Outpatient Surgery Center Financing Works in San Diego
San Diego's outpatient surgery center market operates at the intersection of two powerful structural trends: a regionwide shift toward lower-cost, same-day surgical care and a persistently undersupplied medical real estate stock constrained by geography and regulatory barriers. Health systems including UC San Diego Health, Scripps Health, Sharp HealthCare, and Kaiser Permanente have anchored the metro's clinical infrastructure across multiple campuses, creating a deep referral ecosystem that supports physician-owned ambulatory surgery centers (ASCs) in adjacent and freestanding locations. Submarkets such as La Jolla, Kearny Mesa, Rancho Bernardo, and Carlsbad have become primary concentration zones for outpatient surgical facilities, driven by population density, physician practice density, and proximity to major hospital campuses without the lease cost or operational overhead of on-campus space.
Financing an ASC in San Diego is a fundamentally different exercise than financing a standard medical office building. The real estate underwriting has to account for the specialized physical plant, including operating room suites with medical gas infrastructure, dedicated HVAC, sterile processing areas, and recovery rooms. Beyond physical plant, the licensing stack is the controlling underwriting variable. A San Diego ASC must carry state licensure from the California Department of Public Health, Medicare certification, and typically AAAHC or JCAHO accreditation before a lender treats the facility as a stabilized, income-producing asset. Lenders who lack familiarity with California's ASC licensing timeline and reimbursement structures routinely misprice or decline deals that a specialty-focused lender would close efficiently.
Revenue per square foot in a well-run ASC is materially higher than in conventional medical office, supported by insurance reimbursement streams tied to procedural volume across orthopedics, ophthalmology, gastroenterology, and increasingly, spine and total joint replacement. That cash flow density is what allows lenders to underwrite above the thresholds they would apply to general office, provided the licensing, accreditation, and physician ownership structure are clean. In San Diego, where occupancy across healthcare corridors has remained above 92 percent in core submarkets, a licensed and accredited ASC in a supply-constrained location represents one of the more defensible collateral positions in commercial real estate.
Lender Appetite and Capital Stack for San Diego Outpatient Surgery Center
For physician-owned ASCs structured as owner-occupant acquisitions, SBA 7(a) and SBA 504 programs remain the most competitive execution available in the San Diego market. SBA delivers leverage up to 90 percent loan-to-value for qualifying owner-users, with fixed-rate structures under 504 that are particularly attractive given where the 10-year Treasury is trading in the mid-4 percent range. For a physician partnership acquiring their own surgical facility, the ability to lock long-term fixed-rate debt at meaningful leverage is a structural advantage that conventional financing cannot replicate in the current rate environment.
For institutional ASC operators, joint venture structures with health systems, or deals involving larger multi-specialty platforms like those operated by USPI or Surgery Partners, the capital stack shifts. Regional banks including Pacific Premier Bank and Banner Bank are active in the San Diego market for healthcare-affiliated assets, typically underwriting to 65 to 75 percent LTV with floating rate structures priced at SOFR plus 250 to 375 basis points. With SOFR near 3.6 percent, all-in rates on community and regional bank paper are landing in the high-5 to low-7 percent range depending on credit quality and loan structure. These banks want stabilized, licensed, and accredited facilities. Facilities in lease-up or mid-licensing carry too much execution risk for most balance sheet lenders.
Bridge executions sit with specialty healthcare debt funds, which have been active in submarkets like Kearny Mesa and Rancho Bernardo where value-add or stabilization risk is manageable. Debt fund pricing for ASC bridge debt runs SOFR plus 400 to 600 basis points, with 65 to 70 percent LTV. Prepayment on bridge debt is typically step-down or yield maintenance for the initial term, with extension options tied to licensing and occupancy milestones. Life company and CMBS executions are selective, reserved primarily for large, multi-specialty ASCs with institutional operators and demonstrated reimbursement history. Sponsors pursuing that channel should expect lender due diligence focused heavily on operator creditworthiness, not just real estate fundamentals.
Underwriting Criteria That Matter in San Diego
Lenders underwriting an ASC in San Diego begin with licensing status. A facility without Medicare certification has no reimbursable revenue stream, which means it cannot be underwritten as an operating business. California's CDPH review timeline for ASC licensure adds meaningful execution risk that lenders price into their structure, either through holdbacks, rate stepdowns tied to certification events, or by declining to close until licensure is confirmed. Sponsors who underestimate the licensing timeline and bring a deal to market prematurely consistently struggle to close on schedule.
Physician ownership structure is the second critical variable. Lenders financing physician-owned ASCs need to understand the partnership agreement, revenue allocation, and continuity provisions. A facility where a single high-volume surgeon controls the majority of case volume creates key-person concentration risk that most lenders will flag and some will not accept. Diversified, multi-specialty physician ownership with documented case volume across partners is the profile lenders prefer. In the San Diego market, where competition for orthopedic and spine specialists is particularly intense given the military and active-duty patient population, demonstrating physician commitment and non-compete structures is a real underwriting discussion.
Lenders also scrutinize the payor mix carefully. San Diego's military and veteran population creates meaningful VA and TRICARE reimbursement exposure that conventional ASC lenders outside the market may not be familiar with. Understanding TRICARE reimbursement rates relative to commercial payor rates, and how that mix affects net revenue per procedure, is a San Diego-specific underwriting nuance that separates lenders with genuine healthcare experience from generalists attempting to compete in the space.
Typical Deal Profile and Timeline
A representative San Diego ASC financing in the current environment involves total capitalization of $5 million to $40 million for the real estate component, with deal size driven primarily by building size, improvement scope, and whether the transaction involves ground-up development or acquisition of an existing facility. Physician partnership acquisitions using SBA 504 typically fall in the $5 million to $15 million range. Institutional operator deals with bridge-to-permanent structures or life company executions scale higher and involve more complex underwriting timelines.
Sponsors should model a realistic closing timeline of 60 to 90 days for SBA executions once a complete package is submitted, with the licensing status being the variable most likely to extend that timeline. Bridge debt from a healthcare specialty fund can close in 45 to 60 days if the facility is licensed. Institutional life company or CMBS executions typically require 90 to 120 days and involve more extensive third-party reporting on the operator. Lenders will require a licensed healthcare real estate appraiser, a Phase I environmental, and in most cases a property condition assessment. For SBA deals, the lender will also require business financial statements, physician K-1s, and a business plan with procedure volume projections.
Common Execution Pitfalls Specific to San Diego
The most frequent pitfall is misreading the California CDPH licensure timeline. Sponsors who sign purchase contracts without accounting for the state's ASC application review process, which can run six months or longer for new facilities, routinely miss their closing window and either lose deposits or take bridge debt at elevated cost to extend. Working backward from a realistic licensure date is a prerequisite for structuring a financeable deal.
A second pitfall is approaching conventional lenders without healthcare experience. San Diego's strong general commercial real estate lending environment attracts generalist lenders who will engage on an ASC deal but cannot underwrite the licensing, reimbursement, or physician ownership variables with any precision. The result is retrades, extended due diligence, or conditions that cannot be cleared. Sponsors lose time they cannot recover in a competitive acquisition process.
Third, sponsors frequently underestimate the tenant improvement and build-out costs required to bring a Class B shell to ASC standards. Medical gas, specialized HVAC, electrical upgrades, and sterile processing infrastructure add material cost that affects both the loan amount and the lender's willingness to fund construction risk. Deals that arrive with a construction budget that has not been validated by a healthcare general contractor tend to get reunderwritten downward at credit approval, creating capital gaps late in the process.
Finally, physician key-person concentration is a consistent credit issue in San Diego's surgical specialties. A facility where one surgeon accounts for a disproportionate share of case volume will be flagged by every experienced lender. Sponsors who have not addressed this structurally, through partnership agreements, case volume diversification, or business interruption coverage, will face credit conditions or pricing adjustments that could have been anticipated with earlier lender engagement.
If you have an outpatient surgery center acquisition or development under contract in San Diego or anywhere in California, CLS CRE has the lender relationships and healthcare lending experience to structure the right execution. Trevor Damyan and the CLS CRE team have worked across the full capital stack for ASC and medical office transactions nationally, from SBA owner-occupant acquisitions to institutional bridge and permanent placements. Contact us directly to discuss your deal or access the full program guide for outpatient surgery center financing at clscre.com.